CABENUVA approved by the FDA as first long-acting HIV regimen
The U.S FDA has given the green light to Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for
Read more
DISEASES
Boehringer Ingelheim and Enara Bio join forces to develop new Cancer Immunotherapies
Boehringer Ingelheim and Enara Bio reported that they have entered into a strategic partnership and licensing agreement to study and
Read more
Baxter enters Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine
Baxter International Inc., a world pioneer in the manufacture and supply of sterile medicines, revealed that Baxter BioPharma Solutions has
Read more
Sanofi to purchase Kymab and add OX40L monoclonal antibody to its pipeline
Sanofi is set to acquire Cambridge, UK-headquartered Kymab and thereby add KY1005 to its pipeline, a human monoclonal antibody targeting
Read more
EC and UK authorise Moderna’s RNA-based COVID-19 Vaccine
The EC and UK have granted authorisation for the use of the Moderna COVID-19 Vaccine in individuals 18 years of
Read more
UK approves AstraZeneca and Oxford University COVID-19 vaccine
Drug regulators in the United Kingdom have approved a second COVID-19 vaccine for emergency use today, for the active immunisation
Read more
European Union starts COVID-19 vaccination program
European Union nations, including France, Germany, Italy, Austria, the Czech Republic, Bulgaria, Greece, Latvia, Portugal and Spain have commenced mass
Read more
UK could approve AstraZeneca’s COVID-19 vaccine as early as next week
The United Kingdom could approve AstraZeneca’s COVID-19 vaccine as early as next week as the British-swedish pharmaceutical company seems to
Read more
Moderna’s COVID-19 vaccine approved by the FDA for emergency use
The U.S. FDA has approved Moderna’s COVID-19 vaccine for emergency use. Moderna’s vaccine becomes the second to be approved by
Read more
SenseAnywhere to solve Europe’s COVID-19 vaccine supply chain challenge
Dutch data logger manufacturer, SenseAnywhere, offers a simple solution to overcome the COVID-19 vaccine supply chain challenge. The company has
Read more